How to Value an Orthopedic Spine Surgery Practice in 2026

Spine surgery practices sit at the intersection of the highest-acuity, highest-reimbursement procedures in orthopedics and the most aggressive private equity consolidation wave in healthcare. I've worked on spine practice transactions where a two-surgeon group sold for more than a 20-provider primary care network — and the math made perfect sense once you understood the economics.

Spine is not valued like general orthopedics. The case mix, implant economics, facility ownership, and referral dynamics create a valuation profile that demands specialized understanding. Here's how it actually works.

The Range: 8-16x EBITDA

Spine surgery practices trade at 8-16x EBITDA, making them among the most highly valued physician practice specialties in the market. That range is wide because there's an enormous difference between a solo spine surgeon generating $1M in EBITDA from a hospital-employed model and a multi-surgeon group that owns an ASC, controls its implant economics, and has diversified referral sources.

At the lower end (8-10x), you typically see practices where the surgeons are primarily operating at third-party hospitals, have limited ancillary revenue, and are dependent on a small number of referring physicians. At the upper end (12-16x), you're looking at groups that own or co-own an ambulatory surgery center, have built a vertically integrated model with physical therapy and pain management, and demonstrate consistent case volume growth.

The buyer pool at these multiples is almost exclusively private equity-backed platforms and large orthopedic management companies. Groups like HOPCo, OrthoNow, and various PE-backed musculoskeletal platforms are actively acquiring spine practices because the unit economics are extraordinary — a single spine fusion generates more revenue than most primary care physicians produce in a month.

Surgical Case Volume Is the Core Metric

Buyers underwrite spine practices on case volume first, revenue second. A surgeon performing 250+ cases per year is operating at high capacity and represents reliable, predictable revenue. A surgeon doing 100 cases per year raises questions about referral pipeline, payer access, or clinical reputation.

The composition of that case volume matters as much as the total number. Buyers segment cases into three tiers:

• Complex fusion and reconstruction: Lumbar fusions, cervical fusions, deformity corrections, revision surgeries. These are the highest-reimbursement cases ($30K-$100K+ per case) and represent the core value driver.
• Minimally invasive and decompression: Microdiscectomies, laminectomies, endoscopic procedures. Lower reimbursement ($8K-$25K) but faster throughput and increasingly performable in an ASC setting.
• Interventional pain: Epidural injections, facet blocks, spinal cord stimulator trials. High volume, lower reimbursement per procedure, but excellent margins and a feeder for surgical conversion.

A practice with a balanced mix across all three tiers is more valuable than one concentrated in any single category. The pain and minimally invasive procedures provide volume stability and patient flow, while complex fusions drive the outsized economics.

Implant Vendor Relationships and Economics

This is where spine valuation gets genuinely different from every other medical specialty. Spinal implants — rods, screws, cages, artificial discs — represent a massive cost component, often $5K-$30K per case. The practice's relationship with implant vendors (Medtronic, NuVasive, Stryker Spine, Globus Medical, DePuy Synthes) directly impacts profitability.

Practices that have negotiated favorable implant pricing — whether through volume commitments, group purchasing organizations, or direct relationships — carry meaningfully higher margins. I've seen EBITDA margins swing by 8-12 percentage points based purely on implant cost management.

Some sophisticated spine groups have gone further, investing in surgeon-designed implant companies or obtaining equity stakes in device startups. While this creates potential conflicts of interest that require careful compliance management, it also represents a secondary revenue stream that buyers value highly — particularly when structured properly under Stark Law and Anti-Kickback provisions.

Buyers will scrutinize implant contracts during due diligence. Exclusive vendor arrangements that lock the practice into above-market pricing are a negative. Flexibility to source implants competitively is a positive.

ASC Ownership: The Valuation Multiplier

Owning or co-owning an ambulatory surgery center is the single largest valuation premium in spine. The shift toward outpatient spine surgery — driven by improved minimally invasive techniques, better anesthesia protocols, and aggressive payer pressure — means that an increasing percentage of spine cases can be performed outside the hospital.

When a spine surgeon operates at a hospital, the facility collects the facility fee (often $15K-$50K) and the surgeon collects only the professional fee. When that same surgeon operates at their own ASC, the practice captures both components. The economic difference is transformational.

A spine practice with ASC ownership typically generates 40-60% higher EBITDA per surgeon than an equivalent practice operating exclusively at hospitals. Buyers know this and price it in — ASC-owning spine practices consistently trade at the upper end of the 12-16x range, and in some cases above it.

The caveat is that ASC ownership also introduces operational complexity: accreditation, staffing, equipment maintenance, and separate compliance requirements. Buyers evaluate whether the ASC is well-managed and properly credentialed, not just that it exists.

Workers' Comp and PI Litigation Referrals

Spine practices with established workers' compensation and personal injury litigation referral pipelines occupy a unique valuation position. These cases carry distinct economics: higher reimbursement per case but longer collection cycles, more administrative burden, and regulatory risk.

Workers' comp spine cases reimburse at rates significantly above commercial insurance — in many states, 150-300% of Medicare rates for the same CPT codes. A practice with a mature workers' comp referral network from occupational medicine clinics, employers, and attorneys generates premium revenue per case.

Personal injury cases are even more lucrative on a per-case basis but come with the longest collection timelines — often 12-24 months until settlement. Buyers discount PI revenue more heavily because of the collection uncertainty, but they still value the relationships with referring attorneys as a durable competitive advantage.

The key for valuation is diversification. A practice that's 60%+ dependent on workers' comp or PI referrals is exposed to regulatory changes (fee schedule cuts, treatment guideline restrictions) that can materially impact revenue. Buyers prefer a balanced mix: 40-50% commercial insurance, 20-30% workers' comp, 10-15% PI, and the balance Medicare/Medicaid.

What Drives Spine Practice Value Up

Multiple surgeons. A single-surgeon spine practice carries enormous key-person risk. If the surgeon gets injured, the practice generates zero revenue. Groups with 3+ spine surgeons trade at meaningfully higher multiples because the revenue base survives any single departure.

Referring dentist network equivalent: the PCP and pain management pipeline. Spine surgeons who have cultivated relationships with 50+ referring primary care physicians, pain management specialists, and chiropractors have a durable patient acquisition machine. Buyers value the breadth of the referral network as much as the volume it generates.

Integrated physical therapy. A spine practice with in-house PT captures the post-operative rehabilitation revenue stream. Since virtually every spine surgery patient needs PT, this is high-probability ancillary revenue that adds directly to EBITDA.

OMFS or fellowship-trained surgeons.Surgeons who completed spine-specific fellowships (at recognized programs) carry clinical credibility that supports premium positioning with both patients and referral sources. Training pedigree doesn't appear on a balance sheet, but it absolutely affects buyer confidence.

What Kills Spine Practice Value

Malpractice history.Spine surgery carries inherently higher malpractice risk than most specialties. Active lawsuits, a pattern of claims, or elevated malpractice premiums signal to buyers that they're acquiring litigation risk along with the practice. Clean claims history is table stakes.

Declining case volume. Two years of flat or declining surgical case counts is a serious red flag. Buyers will question whether referral relationships are eroding, whether payer networks have been lost, or whether the surgeons are slowing down clinically.

Hospital system dependency. If 80%+ of your cases are performed at a single hospital, and that hospital decides to recruit competing spine surgeons or renegotiate your block time, your practice is at existential risk. Diversifying across facilities — and ideally owning your ASC — mitigates this.

Compliance exposure.Spine surgery sits in a heavily scrutinized regulatory environment. Implant purchasing patterns, referral relationships, and workers' comp treatment protocols all receive DOJ and OIG attention. Any whiff of Stark Law or Anti-Kickback issues during due diligence will either kill the deal or result in a massive indemnity holdback.

The Bottom Line

Spine surgery practices are among the most valuable physician practices in the M&A market, and for good reason — the unit economics are unmatched, the PE buyer appetite is insatiable, and the consolidation opportunity is real. But achieving the upper end of the 8-16x EBITDA range requires more than just being a busy surgeon. It requires ASC ownership, diversified referral sources, disciplined implant economics, multiple providers, and clean compliance history. The practices that check those boxes are getting aggressive offers in 2026. The ones that don't are leaving millions on the table.